Research
Print page Print page
Switch language
The Capital Region of Denmark - a part of Copenhagen University Hospital
Published

The antihypertensive effect of fermented milk in individuals with prehypertension or borderline hypertension

Research output: Contribution to journalJournal articleResearchpeer-review

DOI

  1. Low-dose spironolactone reduces plasma fibulin-1 levels in patients with type 2 diabetes and resistant hypertension

    Research output: Contribution to journalJournal articleResearchpeer-review

  2. The association between aortic augmentation index and cardiovascular risk factors in a large unselected population

    Research output: Contribution to journalJournal articleResearchpeer-review

  3. Increased ET(A) and ET(B) receptor contraction in the left internal mammary artery from patients with hypertension

    Research output: Contribution to journalJournal articleResearchpeer-review

  1. The Polygenic and Monogenic Basis of Blood Traits and Diseases

    Research output: Contribution to journalJournal articleResearchpeer-review

  2. Trans-ethnic and Ancestry-Specific Blood-Cell Genetics in 746,667 Individuals from 5 Global Populations

    Research output: Contribution to journalJournal articleResearchpeer-review

  3. Cardiac Troponin I and Incident Stroke in European Cohorts: Insights From the BiomarCaRE Project

    Research output: Contribution to journalJournal articleResearchpeer-review

  4. Hypophosphatemic Hypovitaminosis D induces Osteomalacia in the adult female rat

    Research output: Contribution to journalJournal articleResearchpeer-review

View graph of relations
Fermented milk (FM) with putative antihypertensive effect in humans could be an easy applicable lifestyle intervention against hypertension. The mode of action is supposed to be through active milk peptides, shown to possess in vitro ACE-inhibitory effect. Blood pressure (BP) reductions upto 23 mm Hg have been reported in spontaneously hypertensive rats fed FM. Results from human studies of the antihypertensive effect are inconsistent. However, many studies suffer from methodological weaknesses, as insufficient blinding and the use of office BP measurements. We conducted a randomised, double-blind placebo-controlled study of the antihypertensive effect of Lactobacillus helveticus FM in 94 prehypertensive and borderline hypertensive subjects. The participants were randomised into three treatment groups with a daily intake of 150 ml of FM, 300 ml of FM or placebo (chemically acidified milk). The primary outcome was repeated 24-h ambulatory BP measurements. There were no statistically significant differences in the outcome between the groups (systolic BP (SBP), P=0.9; diastolic BP (DBP), P=0.2). However, the group receiving 300 ml FM had reduced BP across the 8-week period in several readings, which could be compatible with a minor antihypertensive effect. Heart rate and lipids remained unchanged between groups. Hence, our study does not support earlier studies measuring office BP-measurements, reporting antihypertensive effect of FM. Based on straight performed 24-h ambulatory BP measurements, milk fermented with Lactobacillus helveticus does not posses significant antihypertensive effect.
Original languageEnglish
JournalJournal of Human Hypertension
Volume24
Issue number10
Pages (from-to)678-83
Number of pages6
ISSN0950-9240
DOIs
Publication statusPublished - 1 Oct 2010

ID: 31002738